Rivastigmine interferes with the pharmacological activity of hydromethylthionine on presynaptic proteins in the line 66 model of frontotemporal dementia
The negative interference of treatments between the acetylcholinesterase inhibitor rivastigmine and the tau aggregation inhibitor hydromethylthionine mesylate (HMTM) has been reported in Line 1 tau-transgenic mice, which overexpress a truncated species of tau protein that is found in the core of pai...
Saved in:
| Main Authors: | Karima Schwab, Lianne Robinson, Anne Annschuetz, Eline Dreesen, Mandy Magbagbeolu, Valeria Melis, Franz Theuring, Charles R. Harrington, Claude M. Wischik, Gernot Riedel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Brain Research Bulletin |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S036192302400306X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rivastigmine to treat anticholinergic toxicity following drug overdose – case series
by: Joseph E. Lambson, et al.
Published: (2025-12-01) -
Effects of CAPAH, memantine, and rivastigmine on behavioral and cognitive functions of rats
by: D. O. Nikitin, et al.
Published: (2024-11-01) -
The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications
by: Jabril Eldufani, et al.
Published: (2019-01-01) -
Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study
by: Piñol Ripoll G, et al.
Published: (2025-04-01) -
Persistence and adherence to rivastigmine in patients with dementia: Results from a noninterventional, retrospective study using the National Health Insurance research database of Taiwan
by: Chee‐Jen Chang, et al.
Published: (2019-01-01)